CONNECTED HEALTH CONFERENCE • Boston, MA • October 25-27, 2017
Teva Respiratory develops and delivers high-quality treatment options for respiratory conditions, including asthma, COPD and allergic rhinitis. Our portfolio of products is centered on optimizing respiratory treatment for patients and healthcare providers through the development of novel delivery systems and therapies that help address unmet needs. Through research and clinical development, Teva Respiratory continually works to expand, strengthen and build upon its treatment portfolio to positively impact the lives of the millions of patients living with respiratory disease. Standing at the forefront of the evolving respiratory care landscape, we will deliver a new Connected Respiratory system incorporating previously unseen experiences, beliefs & behaviour change. Stop by our booth to learn more.